Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

Related Articles by Review for PubMed (Select 19456829)

1.

Treatment of cavitary and infiltrating pulmonary tuberculosis with and without the immunomodulator Dzherelo.

Zaitzeva SI, Matveeva SL, Gerasimova TG, Pashkov YN, Butov DA, Pylypchuk VS, Frolov VM, Kutsyna GA.

Clin Microbiol Infect. 2009 Dec;15(12):1154-62. doi: 10.1111/j.1469-0691.2009.02760.x. Epub 2009 May 16.

2.
3.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
4.

[Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].

Shishido Y, Nagayama N, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Komatsu H, Yotsumoto H.

Kekkaku. 2003 Nov;78(11):683-9. Review. Japanese.

PMID:
14672045
5.

Fluoroquinolones for the treatment of pulmonary tuberculosis.

Moadebi S, Harder CK, Fitzgerald MJ, Elwood KR, Marra F.

Drugs. 2007;67(14):2077-99. Review.

PMID:
17883288
6.

Adjunctive therapy with interferon-gamma for the treatment of pulmonary tuberculosis: a systematic review.

Gao XF, Yang ZW, Li J.

Int J Infect Dis. 2011 Sep;15(9):e594-600. doi: 10.1016/j.ijid.2011.05.002. Epub 2011 Jun 28. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk